New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of prior antibody status, in adult patients with moderate to...
JAKARTA, Indonesia, April 7, 2025 /PRNewswire/ -- The Australian government recently introduced the Circular Economy Framework, a strategic initiative designed to boost sustainability and...
CHENGDU, China, April 6, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced that the prestigious medical journal Nature Medicine...